Deutsche Märkte geschlossen

Halozyme Therapeutics, Inc. (HALO)

NasdaqGS - NasdaqGS Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
47,83-0,44 (-0,91%)
Ab 3:47PM EST. Markt geöffnet.
Melden Sie sich an, um eine Nachricht zu posten.
  • S
    Sean 007
    For a fun experiment (different industries, I know but fun nonetheless):

    Tesla $TSLA
    Average year-over-year sales growth over past 5 years = 50% (from CSI Market)
    Net Cash Flow 5 Year Avg. Change = 18.78 % (from CSI Market)
    Forward PE = 216 (from FinViz)

    Halo $halo
    Expected CAGR of 40% year over year (from the JP Morgan presentation today)
    Expected earnings growth of 50% year over year
    Forward PE = 25 (from FinViz)
  • G
    Gnomer
    $AGEEF conversation
    Kiran Sidhu
    @kiransidhuCEO
    Combined with Winberry, $HALO is one of the largest players in Oregon! That being said, we have a spectacular masterplan for California - the BarX farm!

    Preach!
  • J
    JMC369
    $AGEEF conversation
    Halo Labs Inc.
    @halolabsinc
    ·
    39m
    From all of us @halolabsinc
    , we thank you for your patience and assure you, we will not stop until we have the final signature

    #BOPHELO #lesothocannabis
    Quote Tweet
    Kiran Sidhu
    @kiransidhuCEO
    · 54m
    Last Wed, Central Bank of Lesotho re-opened. We have been in communication & will follow-up this morning.

    It’s been a long journey, but please stay patient. I give my assurance that myself and the entire $HALO team are continuing to work tirelessly until we have the final stamp.
  • G
    Gnomer
    $AGEEF conversation
    It's happening!

    Kiran-

    "Just landed in Johannesburg. Sunday 8am. 26 hour trip. Finalize signing docs in a few hours"

    "30 hours later, the $HALO team has made it to Joburg. Our day has been filled with meetings with Louisa Mojela and the team at her office. Although already a contribution to $HALO, we intend to appoint Louisa as the Chairman of the Board upon closing of Bophelo acquisition."
  • I
    IseeAll
    $HALO is breaking thru the wall of warrants...
  • D
    Dome
    $AGEEF conversation
    From Kiran's twitter 44 minutes ago:

    Up all night…feels like the final yard of a long marathon.
    $HALO
    @halolabsinc
    #bophelo
  • b
    b
    We at $HALO are honored that the NEO exchange chose us to be one of the featured companies on their new billboard campaign. @halolabsinc
  • O
    Othonas
    $GILD conversation
    Read about the interesting interview I had with the CEO of EXUMA Biotech #GILD #NVS #HALO
    https://m.benzinga.com/article/15956406
  • B
    Beach
    HALO Labs. Have a look 😉 Cad ticker $HALO // OTCQB $AGEEF On track for over 10 Million a quarter. US play. Enjoy your weekend, all. Much love.
  • S
    Sean 007
    Halozyme Therapeutics $HALO PT Raised to $43.00 at BMO
  • F
    Flóki
    $HALO conversation
    Tremendous upside after the presentation. Closer ties with JNJ. Can we say bidding war for $HALO soon?
  • H
    HALO
    $HALO conversation
    Were going up today!!!!!!!
    And here's a little Christmas present for HALO longs.
    As for the shorts they've always been scrooges anyways.

    Alexion lines up $200M deal with Halozyme to develop a better, easier next-gen followup to Soliris
    $HALO on a roll.
    https://endpts.com/alexion-lines-up-200m-deal-with-halozyme-to-develop-a-faster-easier-next-gen-followup-to-soliris/
    The recent FDA approval for a revised version of Rituxan and human hyaluronidase enzyme (rHuPH20) as an easy injection has pointed Halozyme to a string of collaborations to do the same for a lineup of major drugs on the market. This morning, the biot
    The recent FDA approval for a revised version of Rituxan and human hyaluronidase enzyme (rHuPH20) as an easy injection has pointed Halozyme to a string of collaborations to do the same for a lineup of major drugs on the market. This morning, the biot
    endpts.com
  • B
    Biotech
    $HALO conversation
    My first post on the HALO Yahoo finance board. I bought HALO in 2015 at circa $9.50 and holding on tight. For those of you who have a Twitter account can check my tweets by searching @Biotech2050 + $HALO.

    Our Enhanze platform patent expires in circa 2027 according to Helen but she also said that any new Enhanze combo approved from now through 2027 will be considered a new formulation and a new patent for that formulation kicks in.

    Concurrently I am also a shareholder of ATNM Actinium (link below). They have "Actinium's Antibody Warhead Enabling (AWE) platform can be used to produce AWE conjugates, a highly potent and selective form of targeted therapy." For example by doing a combo of Daratumumab with AWE the potency increases 30 fold (in pre clinical data per link below)

    Basically if HALO were to buyout ATNM they could replicate the model they have with Enhanze and do a triplet offering ex. Daratumumab + AWE + rHuPH20.

    If anyone has contacts with Halozyme management please bring it to their attention.

    https://www.actiniumpharma.com/awe-technology
    AWE Technology :: Actinium Pharmaceuticals, Inc. (ATNM)
    www.actiniumpharma.com
  • a
    arthur
    $HALO conversation
    1 of 586

    Print all In new window
    Halozyme - Eisai And Halozyme Initiate Phase 1b/2 Clinical Trial With First Patient Dosing Of Eribulin In Combination With PEGPH20
  • H
    Hans
    $HALO conversation
    Eileen O’Reilly MD $HALO says "we are planning for success!!" PegpH20 P3, “selection included individuals who have elevated HA in their tumor, which is more common than genetic mutations- the data will be important and potentially could define a new approach to treating PancreaticCancer
  • J
    JeffreyT
    $HALO conversation
    2017 revenue shortfall based on presentation notes released after the bell. I wonder if this factors in the loss of royalties attributable to the loan? Repayment scheduled to begin in 2017.
  • a
    arthur
    $HALO conversation
    piper raised pt from 15 to 18 reiterate overweight
  • J
    JR
    $HALO conversation
    This is only Phase 2 results. This will most likely sell-off as the day progresses as almost all biotechs do. I've learned to wait for the dust to settle before taking a position on these type of PR related moves. I learned the hard way.
  • j
    john
    $HALO conversation
    This could be another head fake, or it could be the beginning of the run that includes 301 results, SWOG, UCSF, Keytruda Dose Expansion, and at least 4 Enhanze targets moving to phase 2/3 studies.

    Maybe it plunges back to the 9s once more. Who knows. But this is a train that you don't want to miss.
  • E
    E
    $HALO conversation
    Phase 2 results out, looking quite positive, stock trading over 13 in pre-market. CC at 8 am.
    I will be listening.